Global Infectious Disease Rapid Diagnostics Testing Market Insights, Size and Growth Forecast To 2028

Global Infectious Disease Rapid Diagnostics Testing Market - By Product (Over-the-Counter [OTC] Rapid Test Product and Professional Rapid Test Product), By Application (Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), and End User (Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa) - Global forecast from 2021-2028.

Published: Jan-2021	Report ID: HLCA2101	Pages: 1 - 118	Formats^*:
Category : Healthcare

The Global infectious disease rapid diagnostics testing market emerge the market growth owing to cost-effective diagnosis device and prevalence of chronic diseases.

The Global infectious disease rapid diagnostics testing market will fuel CAGR in the forecast period from 2021-2028. The prevalence of contagious diseases spreading through pathogens, viruses, and microorganisms coupled with chronic conditions, has emerged the market demand for the global infectious disease rapid diagnostics testing market.

The rapid diagnosis kits market demand emerging due to the rising diseases such as cancer, diabetics, HIV, as well pregnancy kits also contributed to developing the market demand for the global infectious disease rapid diagnostics testing market.

Moreover, In-vitro diagnosis has a prestigious sub-division, molecular diagnosis applied to the fields of infectious disease diagnosis, blood screening, genetic disease diagnosis, and molecular tumor diagnosis. The wide range of uses has promoted the rapid development of the molecular diagnosis industry, which will propel the market demand for global infectious disease early diagnostics testing market.

Product Overview in the Global infectious disease rapid diagnostics testing Market

Based on product, the global infectious disease rapid diagnostics testing market bifurcated into Over the Counter [OTC] Rapid Test Product and Professional Rapid Test Product. The Over the Counter [OTC] Rapid Test Product segment has captured the highest market value in the global infectious disease rapid diagnostics testing market. It is mainly owing to the effective functioning of the quick diagnosis tests kit, which provides accurate and fast results.

Application Overview in the Global infectious disease rapid diagnostics testing Market

Based on the Application, the global infectious disease rapid diagnostics testing market classified into Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others. The infectious diseases hold the largest market share in the global infectious disease rapid diagnostics testing market. The increasing prevalence of chronic diseases such as STD, HIV, and other contagious diseases have bolstered the demand for the infectious disease early diagnostics testing and will continue to strengthen in the future as well.

End-User Overview in the Global infectious disease rapid diagnostics testing Market

Based on the End-user, the global infectious disease rapid diagnostics testing segmented into Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others. The Homecare segment has dominated the market of the global infectious disease rapid diagnostics testing market. It is due to the emerging demand for diabetic patients and quick test kits also used for a pregnancy test at home. Therefore, the home care segment is fueling the market share of the global infectious disease rapid diagnostics testing market.

Region Overview in the Global infectious disease rapid diagnostics testing Market

Based on geography, the global infectious disease rapid diagnostics testing market segmented into North America, Asia Pacific, Europe, South America, and Middle East & Africa. The North America region will be expecting to witness the highest growth during the forecast period from 2021-2028. Owing to technological advancement, the adoption of the rapid diagnostic testing device, and investment in research and development for the manufacturing of new methods used in the healthcare industry are emerging market of infectious disease quick diagnostics testing market of North America.

Global infectious disease rapid diagnostics testing Market: Competitive Landscape

Companies such as

Abbott Laboratories
Becton
Dickinson and Company
BiomÃ©rieux SA
Danaher Corporation
Bio-Rad Laboratories
Diasorin
Luminex
Quidel
Meridian Bioscience
Roche Diagnostics
Siemens AG
Thermo Fisher Scientific

and others are key players in the global infectious disease rapid diagnostics testing market.

1. Research Strategic Development

1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation

2. Research Methodology

2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation

3. Executive Summary

4. Market Insights

4.1. Economic Factor Analysis

4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges

4.2. Competitors & Product Analysis
4.3. Regulatory Framework
4.4. Company market share analysis, 2021
4.5. Porterâ€™s Five forces analysis
4.6. New Investment Analysis
4.7. PESTEL Analysis

5. Global Infectious Disease Rapid Diagnosis Testing Market Overview

5.1. Market Size & Forecast, 2016-2028

5.1.1. Demand
5.1.1.1. By Value (USD Million)

5.2. Market Share & Forecast, 2016-2028

5.2.1. By Product
5.2.1.1. Over-the-Counter (OTC) Rapid Test Product
5.2.1.2. Professional Rapid Test Product
5.2.2. By Application
5.2.2.1. Infectious Disease
5.2.2.2. Cardiology
5.2.2.3. Oncology
5.2.2.4. Pregnancy & Fertility
5.2.2.5. Toxicology
5.2.2.6. Glucose Monitoring
5.2.2.7. Others
5.2.3. By End-use
5.2.3.1. Hospital & Clinic
5.2.3.2. Diagnostic Laboratory
5.2.3.3. Home Care
5.2.3.4. Others
5.2.4. By Region
5.2.4.1. Europe
5.2.4.2. North America
5.2.4.3. Asia Pacific
5.2.4.4. South America
5.2.4.5. Middle East & Africa

6. Europe Infectious Disease Rapid Diagnosis Testing Market Overview

6.1. Europe Infectious Disease Rapid Diagnosis Testing Size & Forecast, 2016-2028

6.1.1. Demand
6.1.1.1. By Value (USD Million)

6.2. Europe Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028

6.2.1. By Product
6.2.1.1. Over-the-Counter (OTC) Rapid Test Product
6.2.1.2. Professional Rapid Test Product
6.2.2. By Application
6.2.2.1. Infectious Disease
6.2.2.2. Cardiology
6.2.2.3. Oncology
6.2.2.4. Pregnancy & Fertility
6.2.2.5. Toxicology
6.2.2.6. Glucose Monitoring
6.2.2.7. Others
6.2.3. By End-use
6.2.3.1. Hospital & Clinic
6.2.3.2. Diagnostic Laboratory
6.2.3.3. Home Care
6.2.3.4. Others
6.2.4. By Country
6.2.4.1. Germany
6.2.4.2. UK
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Rest of Europe
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on Europe Infectious Disease Rapid Diagnosis Testing Market

7. North America Infectious Disease Rapid Diagnosis Testing Market Overview

7.1. North America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028

7.1.1. Demand
7.1.1.1. By Value (USD Million)

7.2. North America Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028

7.2.1. By Product
7.2.1.1. Over-the-Counter (OTC) Rapid Test Product
7.2.1.2. Professional Rapid Test Product
7.2.2. By Application
7.2.2.1. Infectious Disease
7.2.2.2. Cardiology
7.2.2.3. Oncology
7.2.2.4. Pregnancy & Fertility
7.2.2.5. Toxicology
7.2.2.6. Glucose Monitoring
7.2.2.7. Others
7.2.3. By End-use
7.2.3.1. Hospital & Clinic
7.2.3.2. Diagnostic Laboratory
7.2.3.3. Home Care
7.2.3.4. Others
7.2.4. By Country
7.2.4.1. US
7.2.4.2. Canada
7.2.4.3. Mexico
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on North America Infectious Disease Rapid Diagnosis Testing Market

8. Asia Pacific Infectious Disease Rapid Diagnosis Testing Overview

8.1. Asia Pacific Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028

8.1.1. Demand
8.1.1.1. By Value (USD Million)

8.2. Asia Pacific Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028

8.2.1. By Product
8.2.1.1. Over-the-Counter (OTC) Rapid Test Product
8.2.1.2. Professional Rapid Test Product
8.2.2. By Application
8.2.2.1. Infectious Disease
8.2.2.2. Cardiology
8.2.2.3. Oncology
8.2.2.4. Pregnancy & Fertility
8.2.2.5. Toxicology
8.2.2.6. Glucose Monitoring
8.2.2.7. Others
8.2.3. By End-use
8.2.3.1. Hospital & Clinic
8.2.3.2. Diagnostic Laboratory
8.2.3.3. Home Care
8.2.3.4. Others
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. Australia
8.2.4.5. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Infectious Disease Rapid Diagnosis Testing Market

9. South America Infectious Disease Rapid Diagnosis Testing Market Overview

9.1. South America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028

9.1.1. Demand
9.1.1.1. By Value (USD Million)

9.2. South America Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028

9.2.1. By Product
9.2.1.1. Over-the-Counter (OTC) Rapid Test Product
9.2.1.2. Professional Rapid Test Product
9.2.2. By Application
9.2.2.1. Infectious Disease
9.2.2.2. Cardiology
9.2.2.3. Oncology
9.2.2.4. Pregnancy & Fertility
9.2.2.5. Toxicology
9.2.2.6. Glucose Monitoring
9.2.2.7. Others
9.2.3. By End-use
9.2.3.1. Hospital & Clinic
9.2.3.2. Diagnostic Laboratory
9.2.3.3. Home Care
9.2.3.4. Others
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Infectious Disease Rapid Diagnosis Testing Market

10. Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Overview

10.1. Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2028

10.1.1. Demand
10.1.1.1. By Value (USD Million)

10.2. Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2028

10.2.1. By Product
10.2.1.1. Over-the-Counter (OTC) Rapid Test Product
10.2.1.2. Professional Rapid Test Product
10.2.2. By Application
10.2.2.1. Infectious Disease
10.2.2.2. Cardiology
10.2.2.3. Oncology
10.2.2.4. Pregnancy & Fertility
10.2.2.5. Toxicology
10.2.2.6. Glucose Monitoring
10.2.2.7. Others
10.2.3. By End-use
10.2.3.1. Hospital & Clinic
10.2.3.2. Diagnostic Laboratory
10.2.3.3. Home Care
10.2.3.4. Others
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market

11. Competitor Analysis

11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile

11.7.1.1. Abbott Laboratories
11.7.1.2. Becton, Dickinson and Company
11.7.1.3. BiomÃ©rieux SA
11.7.1.4. Bio-Rad Laboratories
11.7.1.5. Danaher Corporation
11.7.1.6. Diasorin
11.7.1.7. Luminex
11.7.1.8. Meridian Bioscience
11.7.1.9. Quidel
11.7.1.10. Roche Diagnostics
11.7.1.11. Siemens AG
11.7.1.12. Thermo Fisher Scientific
11.7.1.13. Other players

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1